154 related articles for article (PubMed ID: 23435839)
1. Expression of inflammation-mediated cluster of genes as a new marker of canine mammary malignancy.
Pawłowski KM; Homa A; Bulkowska M; Majchrzak K; Motyl T; Król M
Vet Res Commun; 2013 Jun; 37(2):123-31. PubMed ID: 23435839
[TBL] [Abstract][Full Text] [Related]
2. Five markers useful for the distinction of canine mammary malignancy.
Pawłowski KM; Maciejewski H; Majchrzak K; Dolka I; Mol JA; Motyl T; Król M
BMC Vet Res; 2013 Jul; 9():138. PubMed ID: 23844591
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
Gama A; Alves A; Schmitt F
Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiles in canine mammary carcinomas of various grades of malignancy.
Pawłowski KM; Maciejewski H; Dolka I; Mol JA; Motyl T; Król M
BMC Vet Res; 2013 Apr; 9():78. PubMed ID: 23587192
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of connexin 26 and connexin 43 mRNA in canine benign and malignant mammary tumours.
Gotoh H; Harada K; Suzuki K; Hashimoto S; Yamamura H; Sato T; Fukumoto K; Hagiwara H; Ishida T; Yamada K; Asano R; Yano T
Vet J; 2006 Jul; 172(1):178-80. PubMed ID: 16772144
[TBL] [Abstract][Full Text] [Related]
6. Possible role of Snail expression as a prognostic factor in canine mammary neoplasia.
Im KS; Kim JH; Kim NH; Yu CH; Hur TY; Sur JH
J Comp Pathol; 2012; 147(2-3):121-8. PubMed ID: 22297072
[TBL] [Abstract][Full Text] [Related]
7. Detection of neurokinin-1 receptor by immunohistochemistry in canine mammary gland tumours.
Song D; Oh YI; Kim JM; Cheon DS; Kim DY; Seo KW
Vet Med Sci; 2020 Nov; 6(4):958-964. PubMed ID: 32657032
[TBL] [Abstract][Full Text] [Related]
8. Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene.
Hsu WL; Huang HM; Liao JW; Wong ML; Chang SC
Vet J; 2009 Apr; 180(1):116-23. PubMed ID: 18061495
[TBL] [Abstract][Full Text] [Related]
9. Expression of HER-2 and nuclear localization of HER-3 protein in canine mammary tumors: histopathological and immunohistochemical study.
Kim JH; Im KS; Kim NH; Yhee JY; Nho WG; Sur JH
Vet J; 2011 Sep; 189(3):318-22. PubMed ID: 20947393
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-8 expression associated with canine mammary tumors.
Zuccari DA; Castro R; Gelaleti GB; Mancini UM
Genet Mol Res; 2011; 10(3):1522-32. PubMed ID: 21863548
[TBL] [Abstract][Full Text] [Related]
11. Expression of tissue factor in canine mammary tumours and correlation with grade, stage and markers of haemostasis and inflammation.
Andreasen EB; Nielsen OL; Tranholm M; Knudsen T; Kristensen AT
Vet Comp Oncol; 2016 Jun; 14(2):191-201. PubMed ID: 24674618
[TBL] [Abstract][Full Text] [Related]
12. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression patterns in canine mammary cancer show significant differences between metastatic and non-metastatic tumours.
Bulkowska M; Rybicka A; Senses KM; Ulewicz K; Witt K; Szymanska J; Taciak B; Klopfleisch R; Hellmén E; Dolka I; Gure AO; Mucha J; Mikow M; Gizinski S; Krol M
BMC Cancer; 2017 Nov; 17(1):728. PubMed ID: 29115935
[TBL] [Abstract][Full Text] [Related]
14. Results of hyperamplification of centrosomes in naturally developing tumors of dogs.
Setoguchi A; Okuda M; Nishida E; Yazawa M; Ishizaka T; Hong SH; Hisasue M; Nishimura R; Sasaki N; Yoshikawa Y; Masuda K; Ohno K; Tsujimoto H
Am J Vet Res; 2001 Jul; 62(7):1134-41. PubMed ID: 11453492
[TBL] [Abstract][Full Text] [Related]
15. cDNA microarray profiles of canine mammary tumour cell lines reveal deregulated pathways pertaining to their phenotype.
Rao NA; van Wolferen ME; van den Ham R; van Leenen D; Groot Koerkamp MJ; Holstege FC; Mol JA
Anim Genet; 2008 Aug; 39(4):333-45. PubMed ID: 18462483
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of IGF-I and IGF-II expression in canine mammary tumours: Prognostic and diagnostic role.
Ozmen O
Acta Vet Hung; 2020 Sep; 68(3):269-274. PubMed ID: 33221734
[TBL] [Abstract][Full Text] [Related]
17. Density of Gr1-positive myeloid precursor cells, p-STAT3 expression and gene expression pattern in canine mammary cancer metastasis.
Król M; Pawłowski KM; Dolka I; Musielak O; Majchrzak K; Mucha J; Motyl T
Vet Res Commun; 2011 Oct; 35(7):409-23. PubMed ID: 21713436
[TBL] [Abstract][Full Text] [Related]
18. The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas.
Klopfleisch R; Lenze D; Hummel M; Gruber AD
Vet J; 2011 Nov; 190(2):236-243. PubMed ID: 21112801
[TBL] [Abstract][Full Text] [Related]
19. Expression and prognostic value of c-met in canine mammary tumours.
Chen YC; Chen YY; Liao JW; Chang SC
Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptors in canine mammary gland tumours.
Sobczak-Filipiak M; Malicka E
Pol J Vet Sci; 2002; 5(1):1-5. PubMed ID: 11944580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
